245 related articles for article (PubMed ID: 15380356)
1. HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion.
Cavrois M; Neidleman J; Yonemoto W; Fenard D; Greene WC
Virology; 2004 Oct; 328(1):36-44. PubMed ID: 15380356
[TBL] [Abstract][Full Text] [Related]
2. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.
Cavrois M; De Noronha C; Greene WC
Nat Biotechnol; 2002 Nov; 20(11):1151-4. PubMed ID: 12355096
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence resonance energy transfer-based HIV-1 virion fusion assay.
Cavrois M; Neidleman J; Bigos M; Greene WC
Methods Mol Biol; 2004; 263():333-44. PubMed ID: 14976375
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.
Schaeffer E; Geleziunas R; Greene WC
J Virol; 2001 Mar; 75(6):2993-3000. PubMed ID: 11222724
[TBL] [Abstract][Full Text] [Related]
6. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
Azad AA
Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase.
Welker R; Kottler H; Kalbitzer HR; Kräusslich HG
Virology; 1996 May; 219(1):228-36. PubMed ID: 8623533
[TBL] [Abstract][Full Text] [Related]
8. [Function of human immunodeficiency virus type 1 nef gene product in virus replication].
Tokunaga K
Hokkaido Igaku Zasshi; 1996 May; 71(3):345-57. PubMed ID: 8752529
[TBL] [Abstract][Full Text] [Related]
9. Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity.
Miller MD; Warmerdam MT; Ferrell SS; Benitez R; Greene WC
Virology; 1997 Aug; 234(2):215-25. PubMed ID: 9268152
[TBL] [Abstract][Full Text] [Related]
10. A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.
Kulkosky J; BouHamdan M; Geist A; Pomerantz RJ
Virology; 1999 Mar; 255(1):77-85. PubMed ID: 10049823
[TBL] [Abstract][Full Text] [Related]
11. Virological importance of the protease-cleavage site in human immunodeficiency virus type 1 Nef is independent of both intravirion processing and CD4 down-regulation.
Pandori M; Craig H; Moutouh L; Corbeil J; Guatelli J
Virology; 1998 Nov; 251(2):302-16. PubMed ID: 9837795
[TBL] [Abstract][Full Text] [Related]
12. Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells.
Iijima S; Nitahara-Kasahara Y; Kimata K; Zhong Zhuang W; Kamata M; Isogai M; Miwa M; Tsunetsugu-Yokota Y; Aida Y
Virology; 2004 Oct; 327(2):249-61. PubMed ID: 15351213
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.
Yao XJ; Kobinger G; Dandache S; Rougeau N; Cohen E
Gene Ther; 1999 Sep; 6(9):1590-9. PubMed ID: 10490769
[TBL] [Abstract][Full Text] [Related]
14. Producer cell-dependent requirement of the Nef protein for efficient entry of HIV-1 into cells.
Tokunaga K; Kojima A; Kurata T; Ikuta K; Inubushi R; Shimano R; Kawamura M; Akari H; Koyama AH; Adachi A
Biochem Biophys Res Commun; 1998 Sep; 250(3):565-8. PubMed ID: 9784383
[TBL] [Abstract][Full Text] [Related]
15. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation.
Chowers MY; Pandori MW; Spina CA; Richman DD; Guatelli JC
Virology; 1995 Oct; 212(2):451-7. PubMed ID: 7571414
[TBL] [Abstract][Full Text] [Related]
16. Protein methylation is required to maintain optimal HIV-1 infectivity.
Willemsen NM; Hitchen EM; Bodetti TJ; Apolloni A; Warrilow D; Piller SC; Harrich D
Retrovirology; 2006 Dec; 3():92. PubMed ID: 17169163
[TBL] [Abstract][Full Text] [Related]
17. Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope.
Zhou J; Aiken C
J Virol; 2001 Jul; 75(13):5851-9. PubMed ID: 11390586
[TBL] [Abstract][Full Text] [Related]
18. Direct visualization of HIV-1 entry: mechanisms and role of cell surface receptors.
Stauber RH; Rulong S; Palm G; Tarasova NI
Biochem Biophys Res Commun; 1999 May; 258(3):695-702. PubMed ID: 10329448
[TBL] [Abstract][Full Text] [Related]
19. The primate lentivirus-encoded Nef protein can regulate several steps of the viral replication cycle.
Collette Y; Olive D
Virology; 1999 Dec; 265(2):173-7. PubMed ID: 10600589
[TBL] [Abstract][Full Text] [Related]
20. Vpr and Vpu are important for efficient human immunodeficiency virus type 1 replication and CD4+ T-cell depletion in human lymphoid tissue ex vivo.
Rücker E; Grivel JC; Münch J; Kirchhoff F; Margolis L
J Virol; 2004 Nov; 78(22):12689-93. PubMed ID: 15507658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
